Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, et al
Patients typically report initial reduction in pain or improvement in mobility within 1 to 2 weeks of starting BPC-157, with substantial healing changes between weeks 4 and 8
Diaz-Hernandez, J
This biochemical process is also involved in the protection against environmental toxicants, carcinogens, dietary toxins and participates in the homeostasis of numerous endogenous molecules, including bilirubin, steroid hormones and biliary acids
There are however, many patients who do not suffer from any of the above historical side effects but rather have dermatologic mild responses like slight swelling or redness around the injection site
The prevalence of ankylosing spondylitis in the United States is estimated at approximately 0.10.5%, meaning hundreds of thousands of Americans live with this condition